 | • レポートコード：MRC2012A4681 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒト用ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト用ワクチンの種類別市場規模（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：CNBG、Walvax Biotechnology、ChengDa Bio、Changsheng Life、Hissen、Zhifei、SANOFI、SINOVAC BIOTECH、Kangtai、GSK、Changchun Baike、Rong An、Adimmune、Tiantan biological、NuoCheng Bio、Zhongyianke Biotech、Hualan Bio、 ・地域別グローバル市場分析 2015年-2020年 ・ヒト用ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ヒト用ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト用ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト用ワクチンの南米市場（ブラジル、アルゼンチン） ・ヒト用ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン ・用途別分析：大人、子供 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Human Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Human Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Human Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Vaccine market has been segmented into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
By Application, Human Vaccine has been segmented into:
Adults
Children
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Human Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Vaccine Market Share Analysis
Human Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Human Vaccine are:
CNBG
Walvax Biotechnology
ChengDa Bio
Changsheng Life
Hissen
Zhifei
SANOFI
SINOVAC BIOTECH
Kangtai
GSK
Changchun Baike
Rong An
Adimmune
Tiantan biological
NuoCheng Bio
Zhongyianke Biotech
Hualan Bio
Among other players domestic and global, Human Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Vaccine, with price, sales, revenue and global market share of Human Vaccine in 2018 and 2019.
Chapter 3, the Human Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Overview of Global Human Vaccine Market
1.4.1 Global Human Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CNBG
2.1.1 CNBG Details
2.1.2 CNBG Major Business
2.1.3 CNBG SWOT Analysis
2.1.4 CNBG Product and Services
2.1.5 CNBG Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Walvax Biotechnology
2.2.1 Walvax Biotechnology Details
2.2.2 Walvax Biotechnology Major Business
2.2.3 Walvax Biotechnology SWOT Analysis
2.2.4 Walvax Biotechnology Product and Services
2.2.5 Walvax Biotechnology Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 ChengDa Bio
2.3.1 ChengDa Bio Details
2.3.2 ChengDa Bio Major Business
2.3.3 ChengDa Bio SWOT Analysis
2.3.4 ChengDa Bio Product and Services
2.3.5 ChengDa Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Changsheng Life
2.4.1 Changsheng Life Details
2.4.2 Changsheng Life Major Business
2.4.3 Changsheng Life SWOT Analysis
2.4.4 Changsheng Life Product and Services
2.4.5 Changsheng Life Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hissen
2.5.1 Hissen Details
2.5.2 Hissen Major Business
2.5.3 Hissen SWOT Analysis
2.5.4 Hissen Product and Services
2.5.5 Hissen Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zhifei
2.6.1 Zhifei Details
2.6.2 Zhifei Major Business
2.6.3 Zhifei Product and Services
2.6.4 Zhifei Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 SANOFI
2.7.1 SANOFI Details
2.7.2 SANOFI Major Business
2.7.3 SANOFI Product and Services
2.7.4 SANOFI Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 SINOVAC BIOTECH
2.8.1 SINOVAC BIOTECH Details
2.8.2 SINOVAC BIOTECH Major Business
2.8.3 SINOVAC BIOTECH Product and Services
2.8.4 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Kangtai
2.9.1 Kangtai Details
2.9.2 Kangtai Major Business
2.9.3 Kangtai Product and Services
2.9.4 Kangtai Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Product and Services
2.10.4 GSK Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Changchun Baike
2.11.1 Changchun Baike Details
2.11.2 Changchun Baike Major Business
2.11.3 Changchun Baike Product and Services
2.11.4 Changchun Baike Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Rong An
2.12.1 Rong An Details
2.12.2 Rong An Major Business
2.12.3 Rong An Product and Services
2.12.4 Rong An Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Adimmune
2.13.1 Adimmune Details
2.13.2 Adimmune Major Business
2.13.3 Adimmune Product and Services
2.13.4 Adimmune Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Tiantan biological
2.14.1 Tiantan biological Details
2.14.2 Tiantan biological Major Business
2.14.3 Tiantan biological Product and Services
2.14.4 Tiantan biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 NuoCheng Bio
2.15.1 NuoCheng Bio Details
2.15.2 NuoCheng Bio Major Business
2.15.3 NuoCheng Bio Product and Services
2.15.4 NuoCheng Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Zhongyianke Biotech
2.16.1 Zhongyianke Biotech Details
2.16.2 Zhongyianke Biotech Major Business
2.16.3 Zhongyianke Biotech Product and Services
2.16.4 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hualan Bio
2.17.1 Hualan Bio Details
2.17.2 Hualan Bio Major Business
2.17.3 Hualan Bio Product and Services
2.17.4 Hualan Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Human Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Human Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Human Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Human Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Human Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Human Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Human Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Human Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Human Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Human Vaccine Sales and Growth Rate (2015-2020)
6.4 France Human Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Human Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Human Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Human Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Human Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Human Vaccine Sales and Growth Rate (2015-2020)
7.5 India Human Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Human Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Human Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Human Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Human Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Human Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Human Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Human Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Human Vaccine Price by Type (2015-2020)
11 Global Human Vaccine Market Segment by Application
11.1 Global Human Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Human Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Human Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Human Vaccine Market Forecast (2021-2025)
12.2.2 Europe Human Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Vaccine Market Forecast (2021-2025)
12.2.4 South America Human Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Vaccine Market Forecast (2021-2025)
12.3 Human Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Human Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Human Vaccine Market Share Forecast by Type (2021-2025)
12.4 Human Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Human Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Human Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Human Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. CNBG Basic Information, Manufacturing Base and Competitors
Table 9. CNBG Human Vaccine Major Business
Table 10. CNBG Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. CNBG SWOT Analysis
Table 12. CNBG Human Vaccine Product and Services
Table 13. CNBG Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 15. Walvax Biotechnology Human Vaccine Major Business
Table 16. Walvax Biotechnology Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Walvax Biotechnology SWOT Analysis
Table 18. Walvax Biotechnology Human Vaccine Product and Services
Table 19. Walvax Biotechnology Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table 21. ChengDa Bio Human Vaccine Major Business
Table 22. ChengDa Bio Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. ChengDa Bio SWOT Analysis
Table 24. ChengDa Bio Human Vaccine Product and Services
Table 25. ChengDa Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Changsheng Life Basic Information, Manufacturing Base and Competitors
Table 27. Changsheng Life Human Vaccine Major Business
Table 28. Changsheng Life Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. Changsheng Life SWOT Analysis
Table 30. Changsheng Life Human Vaccine Product and Services
Table 31. Changsheng Life Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Hissen Basic Information, Manufacturing Base and Competitors
Table 33. Hissen Human Vaccine Major Business
Table 34. Hissen Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. Hissen SWOT Analysis
Table 36. Hissen Human Vaccine Product and Services
Table 37. Hissen Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Zhifei Basic Information, Manufacturing Base and Competitors
Table 39. Zhifei Human Vaccine Major Business
Table 40. Zhifei Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Zhifei SWOT Analysis
Table 42. Zhifei Human Vaccine Product and Services
Table 43. Zhifei Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. SANOFI Basic Information, Manufacturing Base and Competitors
Table 45. SANOFI Human Vaccine Major Business
Table 46. SANOFI Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. SANOFI SWOT Analysis
Table 48. SANOFI Human Vaccine Product and Services
Table 49. SANOFI Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table 51. SINOVAC BIOTECH Human Vaccine Major Business
Table 52. SINOVAC BIOTECH Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 53. SINOVAC BIOTECH SWOT Analysis
Table 54. SINOVAC BIOTECH Human Vaccine Product and Services
Table 55. SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Kangtai Basic Information, Manufacturing Base and Competitors
Table 57. Kangtai Human Vaccine Major Business
Table 58. Kangtai Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 59. Kangtai SWOT Analysis
Table 60. Kangtai Human Vaccine Product and Services
Table 61. Kangtai Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. GSK Basic Information, Manufacturing Base and Competitors
Table 63. GSK Human Vaccine Major Business
Table 64. GSK Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 65. GSK SWOT Analysis
Table 66. GSK Human Vaccine Product and Services
Table 67. GSK Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Changchun Baike Basic Information, Manufacturing Base and Competitors
Table 69. Changchun Baike Human Vaccine Major Business
Table 70. Changchun Baike Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 71. Changchun Baike SWOT Analysis
Table 72. Changchun Baike Human Vaccine Product and Services
Table 73. Changchun Baike Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Rong An Basic Information, Manufacturing Base and Competitors
Table 75. Rong An Human Vaccine Major Business
Table 76. Rong An Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 77. Rong An SWOT Analysis
Table 78. Rong An Human Vaccine Product and Services
Table 79. Rong An Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Adimmune Basic Information, Manufacturing Base and Competitors
Table 81. Adimmune Human Vaccine Major Business
Table 82. Adimmune Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 83. Adimmune SWOT Analysis
Table 84. Adimmune Human Vaccine Product and Services
Table 85. Adimmune Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Tiantan biological Basic Information, Manufacturing Base and Competitors
Table 87. Tiantan biological Human Vaccine Major Business
Table 88. Tiantan biological Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 89. Tiantan biological SWOT Analysis
Table 90. Tiantan biological Human Vaccine Product and Services
Table 91. Tiantan biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table 93. NuoCheng Bio Human Vaccine Major Business
Table 94. NuoCheng Bio Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 95. NuoCheng Bio SWOT Analysis
Table 96. NuoCheng Bio Human Vaccine Product and Services
Table 97. NuoCheng Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 99. Zhongyianke Biotech Human Vaccine Major Business
Table 100. Zhongyianke Biotech Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 101. Zhongyianke Biotech SWOT Analysis
Table 102. Zhongyianke Biotech Human Vaccine Product and Services
Table 103. Zhongyianke Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 105. Hualan Bio Human Vaccine Major Business
Table 106. Hualan Bio Human Vaccine Total Revenue (USD Million) (2018-2019)
Table 107. Hualan Bio SWOT Analysis
Table 108. Hualan Bio Human Vaccine Product and Services
Table 109. Hualan Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Global Human Vaccine Sales by Manufacturer (2018-2019) (M Doses)
Table 111. Global Human Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 112. Global Human Vaccine Sales by Regions (2015-2020) (M Doses)
Table 113. Global Human Vaccine Sales Market Share by Regions (2015-2020)
Table 114. Global Human Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 115. North America Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 116. North America Human Vaccine Sales Market Share by Countries (2015-2020)
Table 117. North America Human Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 118. North America Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 119. Europe Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 120. Europe Human Vaccine Sales Market Share by Countries (2015-2020)
Table 121. Europe Human Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 122. Asia-Pacific Human Vaccine Sales by Regions (2015-2020) (M Doses)
Table 123. Asia-Pacific Human Vaccine Sales Market Share by Regions (2015-2020)
Table 124. Asia-Pacific Human Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 125. South America Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 126. South America Human Vaccine Sales Market Share by Countries (2015-2020)
Table 127. South America Human Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 128. South America Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 129. Middle East & Africa Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 130. Middle East & Africa Human Vaccine Sales Market Share by Countries (2015-2020)
Table 131. Middle East & Africa Human Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 132. Middle East & Africa Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 133. Global Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 134. Global Human Vaccine Sales Share by Type (2015-2020)
Table 135. Global Human Vaccine Revenue by Type (2015-2020) (USD Million)
Table 136. Global Human Vaccine Revenue Share by Type (2015-2020)
Table 137. Global Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 138. Global Human Vaccine Sales Share by Application (2015-2020)
Table 139. Global Human Vaccine Sales Forecast by Regions (2021-2025) (M Doses)
Table 140. Global Human Vaccine Market Share Forecast by Regions (2021-2025)
Table 141. Global Human Vaccine Sales Forecast by Type (2021-2025) (M Doses)
Table 142. Global Human Vaccine Market Share Forecast by Type (2021-2025)
Table 143. Global Human Vaccine Sales Forecast by Application (2021-2025)
Table 144. Global Human Vaccine Market Share Forecast by Application (2021-2025)
Table 145. Direct Channel Pros & Cons
Table 146. Indirect Channel Pros & Cons
Table 147. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Vaccine Picture
Figure 2. Global Sales Market Share of Human Vaccine by Type in 2019
Figure 3. Varicella Picture
Figure 4. Influenza Picture
Figure 5. Polio Picture
Figure 6. Hepatitis A Picture
Figure 7. Rabies Picture
Figure 8. BCG Picture
Figure 9. Hepatitis B Picture
Figure 10. Pertussis, Diphtheria, Tetanus Picture
Figure 11. Pneumococcal Picture
Figure 12. Rota vaccine Picture
Figure 13. Human Vaccine Sales Market Share by Application in 2019
Figure 14. Adults Picture
Figure 15. Children Picture
Figure 16. Global Human Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Human Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Human Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Human Vaccine Sales Market Share by Manufacturer in 2019
Figure 37. Global Human Vaccine Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Human Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Human Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 42. Global Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Human Vaccine Revenue Market Share by Regions (2015-2020)
Figure 44. Global Human Vaccine Revenue Market Share by Regions in 2018
Figure 45. North America Human Vaccine Sales and Growth Rate (2015-2020)
Figure 46. Europe Human Vaccine Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Human Vaccine Sales and Growth Rate (2015-2020)
Figure 48. South America Human Vaccine Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Human Vaccine Sales and Growth Rate (2015-2020)
Figure 50. North America Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Human Vaccine Sales Market Share by Countries (2015-2020)
Figure 52. North America Human Vaccine Sales Market Share by Countries in 2018
Figure 53. North America Human Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Human Vaccine Revenue Market Share by Countries in 2018
Figure 55. United States Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 56. Canada Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 57. Mexico Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. Europe Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Human Vaccine Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Human Vaccine Revenue Market Share by Countries in 2019
Figure 61. Germany Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 62. UK Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 63. France Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 64. Russia Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 65. Italy Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. Asia-Pacific Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Human Vaccine Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Human Vaccine Revenue Market Share by Regions 2019
Figure 69. China Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 70. Japan Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 71. Korea Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 72. India Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 73. Southeast Asia Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 74. South America Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Human Vaccine Sales Market Share by Countries in 2019
Figure 76. South America Human Vaccine Revenue Market Share by Countries in 2019
Figure 77. Brazil Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 78. Argentina Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 79. Middle East and Africa Human Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Human Vaccine Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Human Vaccine Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Human Vaccine Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 84. Egypt Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 85. Turkey Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 86. South Africa Human Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 87. Global Human Vaccine Sales and Growth Rate (2021-2025) (M Doses)
Figure 88. Global Human Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Human Vaccine Market Forecast (2021-2025) (M Doses)
Figure 90. Europe Sales Human Vaccine Market Forecast (2021-2025) (M Doses)
Figure 91. Asia-Pacific Sales Human Vaccine Market Forecast (2021-2025) (M Doses)
Figure 92. South America Sales Human Vaccine Market Forecast (2021-2025) (M Doses)
Figure 93. Middle East & Africa Sales Human Vaccine Market Forecast (2021-2025) (M Doses)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
ヒト用狂犬病ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rabies Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Rabies Vaccine mar…- ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- ヒトワクチンアジュバントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Vaccine Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Vaccine Adjuvan…
- ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…